FDA Eyes Sentinel Pilot Expansion to Include Public Data Portal

February 1, 2013
When the contract runs out on the FDA’s pilot version of its Sentinel postmarket surveillance program in 2014, the agency plans a three-pronged expansion to include a new data-only portal drugmakers can use for research. Like the Mini-Sentinel pilot, this new “national resource” would be run as a cooperative between the FDA, current and future providers of drug safety surveillance data and others interested in accessing the system’s information.
Drug Industry Daily